Mechanisms of fibrin polymerization and clinical implications

Blood

Volumn 121, Issue 10, 2013, Pages 1712-1719

  Weisel, John W ^a   Litvinov, Rustem I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; ASPARAGINE; BLOOD CLOTTING FACTOR 13A; CALCIUM ION; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIN; FIBRINOGEN; FIBRINOPEPTIDE; GLUTAMINE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; NANOMATERIAL; OLIGOMER; PROLINE; SIALIC ACID;

ACETYLATION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ATOMIC FORCE MICROSCOPY; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS LINKING; DYSFIBRINOGENEMIA; ELECTRON MICROSCOPY; ENVIRONMENTAL FACTOR; FIBRIN CLOT; FIBRIN POLYMERIZATION; FIBRINOLYSIS; GLYCATION; HUMAN; HUMAN CELL; HYDRODYNAMICS; HYDROXYLATION; MICROSCOPY; MOLECULAR MECHANICS; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; THROMBUS; X RAY CRYSTALLOGRAPHY;

EID: 84876458886     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-09-306639     Document Type: Review

References (100)

1. Medved L, Weisel JW. Fibrinogen and Factor XIII Subcommittee of Scientific Standardization Committee of International Society on Thrombosis and Haemostasis. Recommendations for nomenclature on fibrinogen and fibrin. J Thromb Haemost. 2009;7(2):355-359.
2. Riedel T, Suttnar J, Brynda E, et al. Fibrinopeptides A and B release in the process of surface fibrin formation. Blood. 2011;117(5): 1700-1706.
3. Galanakis DK, Henschen A, Peerschke EI, et al. Fibrinogen Stony Brook, a heterozygous A alpha 16Arg -Cys dysfibrinogenemia. Evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly. J Clin Invest. 1989;84(1):295-304. (Pubitemid 19170122)
4. Moen JL, Gorkun OV, Weisel JW, et al. Recombinant BbetaArg14His fibrinogen implies participation of N-terminus of Bbeta chain in desA fibrin polymerization. Blood. 2003;102(7):2466-2471. (Pubitemid 37193584)
5. Litvinov RI, Gorkun OV, Owen SF, et al. Polymerization of fibrin: specificity, strength, and stability of knob-hole interactions studied at the single-molecule level. Blood. 2005;106(9): 2944-2951. (Pubitemid 41565884)
6. Everse SJ, Spraggon G, Veerapandian L, et al. Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry. 1998;37(24): 8637-8642. (Pubitemid 28299601)
7. Kostelansky MS, Betts L, Gorkun OV, et al. 2.8 A crystal structures of recombinant fibrinogen fragment D with and without two peptide ligands: GHRP binding to the "b" site disrupts its nearby calcium-binding site. Biochemistry. 2002;41(40): 12124-12132.
8. Okumura N, Gorkun OV, Lord ST. Severely impaired polymerization of recombinant fibrinogen gamma-364 Asp -. His, the substitution discovered in a heterozygous individual. J Biol Chem. 1997;272(47): 29596-29601. (Pubitemid 27508049)
9. Geer CB, Tripathy A, Schoenfisch MH, et al. Role of 'B-b' knob-hole interactions in fibrin binding to adsorbed fibrinogen. J Thromb Haemost. 2007;5(12):2344-2351. (Pubitemid 350154342)
10. Litvinov RI, Gorkun OV, Galanakis DK, et al. Polymerization of fibrin: Direct observation and quantification of individual B:b knob-hole interactions. Blood. 2007;109(1):130-138. (Pubitemid 46053053)
11. Galanakis D, Spitzer S, Scharrer I. Unusual A alpha 16Arg -.Cys dysfibrinogenaemic family: absence of normal A alpha-chains in fibrinogen from two of four heterozygous siblings. Blood Coagul Fibrinolysis. 1993;4(1):67-71. (Pubitemid 23064918)
12. Okumura N, Terasawa F, Haneishi A, et al. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'. J Thromb Haemost. 2007;5(12):2352-2359. (Pubitemid 350154343)
13. Bowley SR, Lord ST. Fibrinogen variant BbetaD432A has normal polymerization but does not bind knob "B". Blood. 2009;113(18): 4425-4430.
14. Doolittle RF, Pandi L. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. Biochemistry. 2006;45(8):2657-2667.
15. Weisel JW, Medved L. The structure and function of the alpha C domains of fibrinogen. Ann N Y Acad Sci. 2001;936:312-327. (Pubitemid 32613916)
16. Yermolenko IS, Lishko VK, Ugarova TP, et al. High-resolution visualization of fibrinogen molecules and fibrin fibers with atomic force microscopy. Biomacromolecules. 2011;12(2): 370-379.
17. Weisel JW, Warren SG, Cohen C. Crystals of modified fibrinogen: size, shape and packing of molecules. J Mol Biol. 1978;126(2):159-183. (Pubitemid 9088858)
18. Zhmurov A, Brown AE, Litvinov RI, et al. Mechanism of fibrin(ogen) forced unfolding. Structure. 2011;19(11):1615-1624.
19. Mullin JL, Brennan SO, Ganly PS, et al. Fibrinogen Hillsborough: a novel gammaGly309Asp dysfibrinogen with impaired clotting. Blood. 2002;99(10):3597- 3601. (Pubitemid 34534528)
20. Marchi RC, Carvajal Z, Boyer-Neumann C, et al. Functional characterization of fibrinogen Biĉetre II: a gamma 308 Asn -.Lys mutation located near the fibrin D:D interaction sites. Blood Coagul Fibrinolysis. 2006;17(3):193-201.
21. Bowley SR, Okumura N, Lord ST. Impaired protofibril formation in fibrinogen gamma N308K is due to altered D:D and "A:a" interactions. Biochemistry. 2009;48(36):8656-8663.
22. Chernysh IN, Nagaswami C, Weisel JW. Visualization and identification of the structures formed during early stages of fibrin polymerization. Blood. 2011;117(17):4609-4614.
23. Medved' L, Ugarova T, Veklich Y, et al. Electron microscope investigation of the early stages of fibrin assembly. Twisted protofibrils and fibers. J Mol Biol. 1990;216(3):503-509. (Pubitemid 120037383)
24. Allan P, Uitte de Willige S, Abou-Saleh RH, et al. Evidence that fibrinogen g' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness. J Thromb Haemost. 2012; 10(6):1072-1080.
25. Cooper AV, Standeven KF, Ariěns RA. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. Blood. 2003; 102(2):535-540. (Pubitemid 36841972)
26. Gersh KC, Nagaswami C, Weisel JW, et al. The presence of gamma' chain impairs fibrin polymerization. Thromb Res. 2009;124(3): 356-363.
27. Yang Z, Mochalkin I, Doolittle RF. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc Natl Acad Sci USA. 2000;97(26):14156-14161. (Pubitemid 32016546)
28. Okumura N, Terasawa F, Hirota-Kawadobora M, et al. A novel variant fibrinogen, deletion of Bbeta111Ser in coiled-coil region, affecting fibrin lateral aggregation. Clin Chim Acta. 2006; 365(1-2):160-167. (Pubitemid 43196433)
29. Langer BG, Weisel JW, Dinauer PA, et al. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem. 1988;263(29): 15056-15063.
30. Mullin JL, Gorkun OV, Lord ST. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism. Biochemistry. 2000; 39(32):9843-9849. (Pubitemid 30626832)
31. Hirota-Kawadobora M, Terasawa F, Yonekawa O, et al. Fibrinogens Kosai and Ogasa: Bbeta15Gly -.Cys (GGT -.TGT) substitution associated with impairment of fibrinopeptide B release and lateral aggregation. J Thromb Haemost. 2003;1(2):275-283.
32. O'Brien ET III, Falvo MR, Millard D, et al. Ultrathin self-assembled fibrin sheets. Proc Natl Acad Sci USA. 2008;105(49):19438-19443.
33. Tsurupa G, Mahid A, Veklich Y, et al. Structure, stability, and interaction of fibrin aC-domain polymers. Biochemistry. 2011;50(37): 8028-8037.
34. Tsurupa G, Pechik I, Litvinov RI, et al. On the mechanism of aC polymer formation in fibrin. Biochemistry. 2012;51(12):2526-2538.
35. Litvinov RI, Yakovlev S, Tsurupa G, et al. Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other. Biochemistry. 2007; 46(31):9133-9142. (Pubitemid 47237388)
36. Collet JP, Moen JL, Veklich YI, et al. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood. 2005;106(12): 3824-3830. (Pubitemid 41739019)
37. Ping L, Huang L, Cardinali B, et al. Substitution of the human aC region with the analogous chicken domain generates a fibrinogen with severely impaired lateral aggregation: fibrin monomers assemble into protofibrils but protofibrils do not assemble into fibers. Biochemistry. 2011;50(42):9066-9075.
38. Kostelansky MS, Lounes KC, Ping LF, et al. Calcium-binding site beta 2, adjacent to the "b" polymerization site, modulates lateral aggregation of protofibrils during fibrin polymerization. Biochemistry. 2004;43(9): 2475-2483. (Pubitemid 38327843)
39. Kostelansky MS, Lounes KC, Ping LF, et al. Probing the gamma2 calcium-binding site: studies with gammaD298,301A fibrinogen reveal changes in the gamma294-301 loop that alter the integrity of the "a" polymerization site. Biochemistry. 2007;46(17):5114-5123. (Pubitemid 46683009)
40. Dang CV, Shin CK, Bell WR, et al. Fibrinogen sialic acid residues are low affinity calciumbinding sites that influence fibrin assembly. J Biol Chem. 1989;264(25):15104-15108. (Pubitemid 19237344)
41. Profumo A, Turci M, Damonte G, et al. Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca21 concentration. Biochemistry. 2003;42(42):12335-12348. (Pubitemid 37296510)
42. Lounes KC, Ping L, Gorkun OV, et al. Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that "B-b" interactions have a role in protofibril formation. Biochemistry. 2002;41(16): 5291-5299. (Pubitemid 34411685)
43. Averett LE, Akhremitchev BB, Schoenfisch MH, et al. Calcium dependence of fibrin nanomechanics: the g1 calcium mediates the unfolding of fibrinogen induced by force applied to the "A-a" bond. Langmuir. 2010;26(18): 14716-14722.
44. Park R, Ping L, Song J, et al. Fibrinogen residue gAla341 is necessary for calcium binding and 'A-a' interactions. Thromb Haemost. 2012; 107(5):875-883.
45. Mosesson MW, DiOrio JP, Siebenlist KR, et al. Evidence for a second type of fibril branch point in fibrin polymer networks, the trimolecular junction. Blood. 1993;82(5):1517-1521. (Pubitemid 23263968)
46. Fogelson AL, Keener JP. Toward an understanding of fibrin branching structure. Phys Rev E Stat Nonlin Soft Matter Phys. 2010;81(5): 051922.
47. Ryan EA, Mockros LF, Weisel JW, et al. Structural origins of fibrin clot rheology. Biophys J. 1999;77(5):2813-2826. (Pubitemid 29519524)
48. Chernysh IN, Weisel JW. Dynamic imaging of fibrin network formation correlated with other measures of polymerization. Blood. 2008; 111(10):4854-4861.
49. Ferri F, Greco M, Arcòvito G, et al. Structure of fibrin gels studied by elastic light scattering techniques: dependence of fractal dimension, gel crossover length, fiber diameter, and fiber density on monomer concentration. Phys Rev E Stat Nonlin Soft Matter Phys. 2002;66(1): 011913.
50. Guthold M, Liu W, Stephens B, et al. Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3. Biophys J. 2004;87(6):4226-4236. (Pubitemid 39602925)
51. Evans PA, Hawkins K, Morris RH, et al. Gel point and fractal microstructure of incipient blood clots are significant new markers of hemostasis for healthy and anticoagulated blood. Blood. 2010; 116(17):3341-3346.
52. Yeromonahos C, Polack B, Caton F. Nanostructure of the fibrin clot. Biophys J. 2010; 99(7):2018-2027.
53. Okada M, Blombǎck B. Factors influencing fibrin gel structure studied by flow measurement. Ann N Y Acad Sci. 1983;408:233-253. (Pubitemid 13072040)
54. Spero RC, Sircar RK, Schubert R, et al. Nanoparticle diffusion measures bulk clot permeability. Biophys J. 2011;101(4):943-950.
55. Weisel JW. Cross-linked gamma-chains in fibrin fibrils bridge transversely between strands: no. J Thromb Haemost. 2004;2(3):394-399. (Pubitemid 40185648)
56. Mosesson MW. Cross-linked gamma-chains in fibrin fibrils bridge 'transversely' between strands: yes. J Thromb Haemost. 2004;2(3): 388-393. (Pubitemid 40185647)
57. Guthold M, Carlisle C. Single fibrin fiber experiments suggest longitudinal rather than transverse cross-linking: reply to a rebuttal. J Thromb Haemost. 2010;8(9):2090-2091.
58. Standeven KF, Carter AM, Grant PJ, et al. Functional analysis of fibrin gamma-chain crosslinking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness. Blood. 2007;110(3):902-907. (Pubitemid 47267427)
59. Lim BC, Ariěns RA, Carter AM, et al. Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet. 2003;361(9367): 1424-1431. (Pubitemid 36515043)
60. Hoffman M. Alterations of fibrinogen structure in human disease. Cardiovasc Hematol Agents Med Chem. 2008;6(3):206-211.
61. de Moerloose P, Neerman-Arbez M. Congenital fibrinogen disorders. Semin Thromb Hemost. 2009;35(4):356-366.
62. Weisel JW, Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J. 1992;63(1):111-128.
63. Konings J, Govers-Riemslag JW, Philippou H, et al. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood. 2011; 118(14):3942-3951.
64. Aleman MM, Gardiner C, Harrison P, et al. Differential contributions of monocyte-and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost. 2011;9(11):2251-2261.
65. Collet JP, Montalescot G, Lesty C, et al. A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots. Circ Res. 2002; 90(4):428-434. (Pubitemid 34633912)
66. Campbell RA, Overmyer KA, Bagnell CR, et al. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface. Arterioscler Thromb Vasc Biol. 2008;28(12):2247-2254.
67. Mutch NJ, Engel R, Uitte de Willige S, et al. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. Blood. 2010;115(19):3980-3988.
68. Amelot AA, Tagzirt M, Ducouret G, et al. Platelet factor 4 (CXCL4) seals blood clots by altering the structure of fibrin. J Biol Chem. 2007;282(1): 710-720. (Pubitemid 47076616)
69. Feghhi S, Sniadecki NJ. Mechanobiology of platelets: techniques to study the role of fluid flow and platelet retraction forces at the micro-and nano-scale. Int J Mol Sci. 2011;12(12): 9009-9030.
70. Ovanesov MV, Ananyeva NM, Panteleev MA, et al. Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate. J Thromb Haemost. 2005;3(2): 321-331. (Pubitemid 41623621)
71. Campbell RA, Overmyer KA, Selzman CH, et al. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood. 2009;114(23):4886-4896.
72. Gersh KC, Nagaswami C, Weisel JW. Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes. Thromb Haemost. 2009;102(6):1169-1175.
73. Wolberg AS. Plasma and cellular contributions to fibrin network formation, structure and stability. Haemophilia. 2010;16(suppl): 37-12.
74. Wolberg AS. Determinants of fibrin formation, structure, and function. Curr Opin Hematol. 2012;19(5):349-356.
75. Neeves KB, Illing DA, Diamond SL. Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J. 2010;98(7):1344-1352.
76. Gersh KC, Edmondson KE, Weisel JW. Flow rate and fibrin fiber alignment. J Thromb Haemost. 2010;8(12):2826-2828.
77. Campbell RA, Aleman M, Gray LD, et al. Flow profoundly influences fibrin network structure: implications for fibrin formation and clot stability in haemostasis. Thromb Haemost. 2010;104(6): 1281-1284.
78. Whittaker P, Przyklenk K. Fibrin architecture in clots: a quantitative polarized light microscopy analysis. Blood Cells Mol Dis. 2009;42(1):51-56.
79. Varj ́u I, S'otonyi P, Machovich R, et al. Hindered dissolution of fibrin formed under mechanical stress. J Thromb Haemost. 2011;9(5):979-986.
80. Colace TV, Muthard RW, Diamond SL. Thrombus growth and embolism on tissue factorbearing collagen surfaces under flow: role of thrombin with and without fibrin. Arterioscler Thromb Vasc Biol. 2012;32(6):1466-1476.
81. Katoh M, Haage P, Wiethoff AJ, et al. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study. Invest Radiol. 2009; 44(3):146-150.
82. He S, Bark N, Wang H, et al. Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis. J Cardiovasc Pharmacol. 2009; 53(1):24-29.
83. Yeromonahos C, Marlu R, Polack B, et al. Antithrombin-independent effects of heparins on fibrin clot nanostructure. Arterioscler Thromb Vasc Biol. 2012;32(5):1320-1324.
84. Tehrani S, Mobarrez F, Antovic A, et al. Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. Thromb Res. 2010;126(3):e225-e231.
85. Undas A, Celinska-Lǒwenhoff M, Lǒwenhoff T, et al. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost. 2006;4(5):1029-1036.
86. Standeven KF, Ariěns RA, Whitaker P, et al. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation. Diabetes. 2002;51(1):189-197. (Pubitemid 34517997)
87. Stabenfeldt SE, Gourley M, Krishnan L, et al. Engineering fibrin polymers through engagement of alternative polymerization mechanisms. Biomaterials. 2012;33(2):535-544.
88. Watson JW, Doolittle RF. Peptide-derivatized albumins that inhibit fibrin polymerization. Biochemistry. 2011;50(45):9923-9927.
89. Undas A, Ariěns RA. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol. 2011;31(12): e88-e99.
90. Falati S, Gross P, Merrill-Skoloff G, et al. Realtime in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med. 2002;8(10):1175-1181.
91. Welsh JD, Colace TV, Muthard RW, et al. Platelet-targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse. J Thromb Haemost. 2012;10(11):2344-2353.
92. Silvain J, Collet JP, Nagaswami C, et al. Composition of coronary thrombus in acute myocardial infarction. J Am Coll Cardiol. 2011; 57(12):1359-1367.
93. Collet JP, Allali Y, Lesty C, et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol. 2006;26(11): 2567-2573. (Pubitemid 44607482)
94. Weisel JW. Structure of fibrin: impact on clot stability. J Thromb Haemost. 2007;5(suppl 1): 116-124. (Pubitemid 46958824)
95. Brummel-Ziedins KE, Branda RF, Butenas S, et al. Discordant fibrin formation in hemophilia. J Thromb Haemost. 2009;7(5):825-832.
96. Scott DJ, Prasad P, Philippou H, et al. Clot architecture is altered in abdominal aortic aneurysms and correlates with aneurysm size. Arterioscler Thromb Vasc Biol. 2011;31(12): 3004-3010.
97. Undas A, Podolec P, Zawilska K, et al. Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke. Stroke. 2009;40(4): 1499-1501.
98. Undas A, Zawilska K, Ciesla-Dul M, et al. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. Blood. 2009;114(19):4272-4278.
99. Parastatidis I, Thomson L, Burke A, et al. Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor. J Biol Chem. 2008; 283(49):33846-33853.
100. Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost. 2006;4(5):932-939.